Synthetic derivatives of vinpocetine as antiproliferative agents
Mihira GuttiiD, Melanie Tsui, Stella YangiD, Selina XiiD, Jennifer LuoiD, Arshia DesarkariD, Yining XieiD, Mirabelle Feng, Udbhav Avadhani, Shloka Raghavan, Elena Brierley-GreeniD, Erika Yu, Edward NjooiD
Abstract
Vincamine is an indole alkaloid initially isolated from plants of the Vinca genus and has previously been demonstrated to have antioxidant, hypoglycemic, and hypolipidemic activities. Vinpocetine, a synthetic derivative of vincamine with an enhanced pharmacological profile, has demonstrated promising antiproliferative properties. While previously reported vinpocetine derivatives have undergone extensive investigation for their pharmacological properties, the role of the E-ring ethyl ester in the anticancer properties of compounds with this scaffold has not yet been fully described. Here, we report the antiproliferative activity of two vinpocetine analogs with modifications at the E-ring. MTT assays revealed that reduction of the ethyl ester to an alcohol exhibited strong dose-dependent antiproliferative activity across five mammalian cell lines, but did not induce significant markers of apoptosis or necrotic death as determined by FITC/Annexin V and cell cycle flow cytometry, respectively. We further observe that vinpocetine and both analogs exhibit dose-dependent modulation of a TCF/LEF reporter cell, which appears to be decoupled from trends in antiproliferative activity Altogether, this work demonstrates the potential for E-ring modifications of vinpocetine as anticancer agents.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 20th percentile
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Structural modification of naturally-occurring phenolics as a strategy for developing cytotoxic molecules towards cancer cells
P. A. Olim, R. B. Pereira, … D. M. Pereira·Archiv der PharmaziePeer-reviewed·Oct 11, 2023
- Discovery, optimization, and cellular activities of 2-(aroylamino)cinnamamide derivatives against colon cancer
R. S. Elhaggar, A. M. Omar, … M. E. El-Araby·bioRxiv·Dec 15, 2019
- C19 trityl and silyl andrographolide analogs exhibit in vitro anticancer activity in murine cancer models
Rushika Raval, Ruirui Liu, … Edward Njoo·bioRxiv·Oct 30, 2026
- Alkoxylated fisetin derivatives - the new potential drugs against head and neck cancers
Patryk Chudy, Paulina Wala, … Robert Kubina·bioRxiv·Feb 5, 2026
- Evaluation of anticancer and anti-mitotic properties of quinazoline and quinazolino-benzothiadiazine derivatives
T. B. Shaik, M. S. Malik, … A. Kamal·Anti-Cancer Agents in Medicinal ChemistryPeer-reviewed·May 28, 2020
- Anticancer synthetic arylsulfonamides with Wnt1-modulating activity
Mihira Gutti, Jennifer Luo, … Edward Njoo·Essential ChemPeer-reviewed·Jul 2, 2026